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Invasive Acute Hemodynamic Response to
Guide Left Ventricular Lead Implantation Predicts
Chronic Remodeling in Patients Undergoing
Cardiac Resynchronization Therapy
Simon G. Duckett, MBBS,*† Matthew Ginks, MBBS,*† Anoop K. Shetty, MBBS,*†
Julian Bostock, MSC,† Jaswinder S. Gill, MD,† Shoaib Hamid, MD,† Stam Kapetanakis, MD,†
Eliane Cunliffe, BSC,† Reza Razavi, MD,*† Gerry Carr-White, PHD,† C. Aldo Rinaldi, MD*†
London, United Kingdom
Objectives We evaluated the relationship between acute hemodynamic response (AHR) and reverse remodeling (RR) in car-
diac resynchronization therapy (CRT).
Background CRT reduces mortality and morbidity in heart failure patients; however, up to 30% of patients do not derive symptom-
atic benefit. Higher proportions do not remodel. Multicenter trials have shown echocardiographic techniques are poor
at improving response rates. We hypothesized the degree of AHR at implant can predict which patients remodel.
Methods Thirty-three patients undergoing CRT (21 dilated and 12 ischemic cardiomyopathy) were studied. Left ventricular (LV)
volumes were assessed before and after CRT. The AHR (maximum rate of left ventricular pressure [LV-dP/dtmax]) was
assessed at implant with a pressure wire in the LV cavity. Largest percentage rise in LV-dP/dtmax from baseline (atrial
antibradycardia pacing or right ventricular pacing with atrial fibrillation) to dual-chamber pacing (DDD)-LV was used to
determine optimal coronary sinus LV lead position. Reverse remodeling was defined as reduction in LV end systolic
volume 15% at 6 months.
Results The LV-dP/dtmax increased significantly from baseline (801  194 mm Hg/s to 924  203 mm Hg/s, p  0.001)
with DDD-LV pacing for the optimal LV lead position. The LV end systolic volume decreased from 186  68 ml
to 157  68 ml (p  0.001). Eighteen (56%) patients exhibited RR. There was a significant relationship be-
tween percentage rise in LV-dP/dtmax and RR for DDD-LV pacing (p  0.001). A similar relationship for AHR and
RR in dilated cardiomyopathy and ischemic cardiomyopathy (p  0.01 and p  0.006) was seen.
Conclusions Acute hemodynamic response to LV pacing is useful for predicting which patients are likely to remodel in re-
sponse to CRT both for dilated cardiomyopathy and ischemic cardiomyopathy. Using AHR has the potential to
guide LV lead positioning and improve response rates. (J Am Coll Cardiol 2011;58:1128–36) © 2011 by the
American College of Cardiology Foundation
Published by Elsevier Inc. doi:10.1016/j.jacc.2011.04.042Cardiac resynchronization therapy (CRT) is a well-
established treatment for patients with severe heart failure.
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2011, accepted April 12, 2011.Cardiac resynchronization therapy improves quality of life
(1,2), prognosis (3), and in the long-term is associated with
left ventricular (LV) reverse remodeling (RR) (4). However
a significant number of patients do not derive clinical
benefit. This has led to various strategies particularly with
See page 1137
echocardiographic imaging techniques to improve patient
selection. Nevertheless, recent findings have not supported
the use of echocardiographic-derived dyssynchrony indexes
to guide CRT (5,6).
Maximum rate of left ventricular pressure (LV-dP/dtmax)
is a reproducible marker of LV contractility. Several studies
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September 6, 2011:1128–36 Hemodynamic Response Predicts Remodeling to Resynchronizationhave used acute hemodynamic response (AHR) to determine
lead position (7–9) as well as optimize pacing settings (10,11).
Studies have evaluated the effect of LV pacing in the context of
CRT with LV-dP/dtmax as an endpoint (8,11–13). The
mplication is that acute improvement in contractility translates
nto beneficial effects from CRT in the longer term. Although it
s logical that energy, which is wasted as a result of LV dyssyn-
hrony, might be “harnessed” by LV pacing to improve cardiac
unction, it is likely there are more complex mechanisms involved
n remodeling. Echocardiographic-based assessments of AHR to
RT have shown it is a useful predictor of long-term clinical
utcome (14,15). However, echocardiographic-derived LV-
P/dtmax is confined to patients with enough mitral regur-
itation to obtain a clear signal and is difficult to measure
uring CRT implant. Although it has been shown that
nvasive measurement of AHR improves with CRT (13), it
emains unclear whether an AHR at the time of CRT
quates to RR and improvement in quality of life.
The current consensus is to position the LV lead in a
ateral or posterolateral branch of the coronary sinus (CS)
16,17). A recent study found a marked variation in hemo-
ynamic response, depending on LV pacing position (8).
e hypothesized that AHR at the time of CRT implant
ould help guide lead placement and predict chronic re-
ponse. We used invasive LV-dP/dtmax to guide conven-
tional coronary sinus LV lead placement in an unselected
group of heart failure patients during CRT implant. We
investigated how this related to chronic response by deter-
mining LV remodeling and clinical response at 6 months.
Methods
Patients. Patients fulfilling standard criteria for CRT
(New York Heart Association [NYHA] functional class III
to IV drug refractory heart failure, left ventricular ejection
fraction [LVEF] 35%, LV end-diastolic diameter 55
m, and prolonged QRS 120 ms) were recruited. The
tudy complied with the local ethics committees, and
nformed consent was obtained from each patient. Clinical
haracteristics are presented in Table 1.
chocardiographic assessment. Before CRT, patients un-
erwent echocardiography with a GE Vivid 7 scanner
General Electric-Vingmed, Milwaukee, Wisconsin). Anal-
sis was performed with EchoPac (version 6.0.1, General
lectric-Vingmed). Ejection fractions and LV dimensions
nd volumes were measured with 2-dimensional biplane
impson’s modified method.
The interventricular mechanical delay (IVMD) was cal-
ulated as the difference between the LV and right ventric-
lar (RV) pre-ejection periods measured from the QRS to
nset of pulmonary and aortic flows, respectively (18,19).
ntraventricular dyssynchrony was assessed with tissue
oppler imaging (TDI) by measuring the difference between
eptal to lateral peak velocity within the aortic valve opening
nd closing times (20). Systolic dyssynchrony index (SDI)as measured (21) with TomTec
D LV-Analysis software (TomTec
maging Systems, Inc., Munich,
ermany).
mplant and acute hemodynamic
easurements. During CRT
mplant hemodynamic evaluation
as performed with a 0.014-inch-
iameter high-fidelity Certus
ressureWire and PhysioMon
oftware (Radi Medical Systems,
ppsala, Sweden) with a 500-Hz
requency response introduced
nto the LV through a 5-F mul-
ipurpose catheter from either a
emoral or radial arterial access
ite (22). The multi-purpose
atheter was removed or with-
rawn into the aorta, leaving the
ressure wire in a stable position
ithin the LV cavity. Once ve-
ous access was acquired for pac-
ng lead implants, 2,500 U of
eparin were given, followed by
aline flush (Table 2).
The LV-dP/dtmax was calcu-
ated electronically from every
eartbeat for a period of at least
0 s to ensure steady-state con-
itions. The results were aver-
ged for the complete measure-
ent period. A waiting period of
t least 20 s was respected after
ny change in pacing settings or
ead position to achieve hemody-
amic stabilization (23). This
ethod has previously been
hown to reliably measure LV-dP/dtmax (12).
Hemodynamic measurement protocol and data analysis.
An occlusive venogram was performed, and either Quickflex
LV leads or Quartet Model 1458Q (programmed bipolar
D1-M2) (St. Jude Medical, Sylmar, California) were placed
in branches of the coronary sinus that were considered as
potential targets to allow multiple measurements of dP/
dtmax. In these sites LV-dP/dtmax was measured during
intrinsic rhythm and atrial pacing (atrial antibradycardia
pacing [AAI] 5 to 10 beats above intrinsic atrial rate to
ensure consistent capture) and with LV coronary sinus
pacing (dual-chamber [DDD]-LV [fixed atrioventricular
delay 100 ms] or single-chamber ventricular pacing [pa-
tients in atrial fibrillation], 5 to 10 beats above intrinsic). In
patients with atrial fibrillation, baseline was considered as
RV pacing 5 to 10 beats above intrinsic ventricular rate (24).
Results at each pacing site were expressed as a percentage
change from baseline. The baseline was reassessed before
Abbreviations
and Acronyms
AAI  atrial
antibradycardia pacing
AHR  acute hemodynamic
response
BIV  biventricular
CRT  cardiac
resynchronization therapy
DCM  dilated
cardiomyopathy
DDD  dual-chamber
(pacing)
ESV  end-systolic volume
ICM  ischemic
cardiomyopathy
IVMD  interventricular
mechanical delay
LV  left ventricle/
ventricular
LV-dP/dtmax  maximum
rate of left ventricular
pressure
LVEF  left ventricular
ejection fraction
NYHA  New York Heart
Association
ROC  receiver-operator
characteristic
RR  reverse remodeling
RV  right ventricle/
ventricular
SDI  systolic
dyssynchrony index
TDI  tissue Doppler
imagingevery new LV lead position, and the optimal LV lead
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Hemodynamic Response Predicts Remodeling to Resynchronization September 6, 2011:1128–36position was arbitrarily defined as the location with the largest
percentage rise in LV-dP/dtmax from baseline. The number of
measurements varied, depending on the number of target
branches. To determine baseline drift in dP/dtmax, the SD in
he baseline was calculated for each patient over the course of
he implant and then the mean SD for all the procedures. At
he end of the procedure, pressure wire-guided atrioventricular
nd interventricular optimization was performed.
emodeling and responders. Patients were deemed to
ave RR if there was a 15% reduction in LV end-systolic
olume (ESV) (20,25). Symptomatic response was evalu-
ted by NYHA functional class and quality-of-life question-
aire repeated at 6 months (26). Acute response was defined
s a10% rise in dP/dtmax from baseline to assess sensitivity
nd specificity for dP/dtmax to predict RR. This cutoff value
has been used in previous studies (11,27). Patients were
labeled clinical responders if the NYHA functional class fell
by 1 or if there was a 10% reduction in quality-of-life
questionnaire score.
Patient CharacteristicsTable 1 Patient Characteristics
All Patients
(n  33)
Age (yrs) 63.6 12.1
Male/female 29/4
NYHA functional class III 30
QOL score pre-CRT 52 22
QRS duration (ms) 160 23
Rhythm 27 SR
6 AF
Ejection fraction (%) 25 8
End-diastolic volume (ml) 239 69
ESV (ml) 185 67
Beta-blockers (%) 86
ACE/ARB (%) 100
Diuretics (%) 64
Aldosterone antagonists (%) 39
ACE angiotensin-converting enzyme; AF atrial fibrillation; ARB a
dilated cardiomyopathy; ESV  end-systolic volume; ICM  ischemic
questionnaire; SR  sinus rhythm.
Implant DetailsTable 2 Implant Details
Implant
Device 8 St. Jude Promote Q CD3221
16 St. Jude Promote RF 3213-36
5 St. Jude Pacesetter Atlas II HF v-367
4 St. Jude Frontier II 5596
LV lead position 2 posterior vein
19 posterolateral vein
11 lateral vein
1 middle cardiac vein
1 anterolateral vein
Types of LV lead 27 Quickflex (St. Jude Medical)
6 Quartet Model 1458Q (St. Jude Medical)
LV lead threshold 1.4 0.7
RV lead threshold 0.7 0.3LV  left ventricular; RV  right ventricular.Statistical analysis. Statistical analysis was performed on
JMP (version 8.0.2, Marlow, Buckinghamshire, United
Kingdom). A Shapiro-Wilk test was used to ensure vari-
ables were normally distributed. Continuous variables were
expressed as mean  SD and compared with parametric
(1-way analysis of variance) and nonparametric (Wilcoxon
rank sum) tests. Changes in variables were compared with
paired t tests. Nominal variables are expressed as absolute
ount and percentages and compared with a Fisher exact
est. Outcomes were assessed with logistic regression to
reate receiver-operator characteristic (ROC) curves. Opti-
al cutoffs were selected as the level with the highest
sensitivity  [1  specificity]). Values of p  0.05 were
considered statistically significant.
Results
Patients. Thirty-three patients were studied (29 men, age
63.6  12.1 years), with a mean ejection fraction of 25 
8%. All patients had left bundle branch block (QRS
duration 160  23 ms). Twelve had ischemic cardiomyop-
athy (ICM), and 21 had dilated cardiomyopathy (DCM)
(Table 1). The LV-dP/dtmax was successfully measured in
all patients (Table 2). Average procedure time was 138 38
min and fluoroscopy time 20.7  7.4 min. One groin
ematoma and one wound hematoma occurred, neither
equiring intervention. One RV lead displacement occurred
equiring repositioning the following day. One patient had
coronary sinus dissection; however, an LV lead was
uccessfully implanted. One patient with ICM had excessive
iaphragmatic pacing, which led to the LV lead being
urned off, and was excluded from follow-up.
Mean intrinsic LV-dP/dtmax was 722  148 mm Hg/s,
ncreasing to 801 194 mm Hg/s (p 0.001) with AAI/RV
acing (baseline). Average number of baseline readings was 5.8
DCM
n  21)
ICM
(n  12)
p Value
DCM vs. ICM
.3 12.7 65.9 10.9 NS
18/3 11/1 NS
20 10 NS
0 23 53 21 NS
2 28 156 13 NS
16 SR 11 SR NS
5 AF 1 AF
.4 9.4 25.6 4.9 NS
0 83 229 56 NS
3 77 170 43 NS
88 75
100 100
78 45
41 36
sin receptor blocker; CRT cardiac resynchronization therapy; DCM
yopathy; NYHA  New York Heart Association; QOL  quality of life(
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September 6, 2011:1128–36 Hemodynamic Response Predicts Remodeling to Resynchronizationimplants was 68 17 mm Hg/s. Average number of coronary
inus LV sites tested was 3.3  1.2. There was a highly
ignificant increase in LV-dP/dtmax from baseline to
DDD-LV pacing in the optimal (best AHR) position (801
194 mm Hg/s to 924 203 mm Hg/s, p 0.001, 18 18%
rise) (Fig. 1, Table 3). In 30 of the patients at least 2 separate
branches of the coronary sinus were paced. There was a highly
significant difference between best and worst LV pacing site
(924 203 mm Hg/s best site vs. 782 160 mm Hg/s worst
site, p  0.001) (Figs. 1 and 2). With a 10% cutoff to define
acute response, 23 (70%) of patients acutely responded to
DDD-LV pacing.
Response and remodeling. Pre-implant LVESV and
LVEF were 185 67 ml and 24.8 8.0%, respectively. These
improved at follow-up to 157  69 ml and 32.8  9.7%,
representing a 15% relative reduction in LVESV and a 41%
relative improvement in LVEF (both p  0.001). Eighteen
(56%) patients remodeled with a significant relationship for
percentage rise in dP/dtmax and RR for DDD-LV pacing (p
Figure 1
Change in LV-dP/dtmax for Various Pacing Modes
and Difference Between Best and Worst
LV-dP/dtmax for DDD-LV Pacing
The p values are derived from paired t tests and reflect the change in maxi-
mum rate of left ventricular pressure (LV-dP/dtmax) between pacing positions
and baseline dP/dtmax. AAI  atrial antibradycardia pacing; DDD 
dual-chamber (pacing); LV  left ventricular; RV  right ventricular.
Responders and Hemodynamic Response Depending on LV Lead PoTable 3 Responders and Hemodynamic Response Depending o
>15% Reduction in ESV M
All patients*, n  33 18 (56%)
LV lead posterolateral vein*, n  18 11 (64%)
LV lead lateral vein, n  11 5 (45%)
LV lead posterior vein, n  2 1 (50%)
LV lead middle cardiac vein, n  1 1 (100%)
LV lead anterolateral vein, n  1 0 (0%)Values are n (%), mean  SD, or n. *One patient excluded from long-term follow-up. †Significant diffe
DDD  dual-chamber (pacing); ESV  end-systolic volume; LV  left ventricular; RV  right ventricu.001) (Fig. 3A). There was a good relationship between QRS
uration and RR (p 0.001). Echocardiographic measures of
yssynchrony, left ventricular pre-ejection time, IVMD, and
DI measured with 3-dimensional echocardiography were
ound to have a significant relationship for RR (p 0.01, p
.001, and p  0.01, respectively). Septal-lateral delay with
DI showed no relationship for RR (p  0.8) (Fig. 4).
A 10% improvement in LV-dP/dtmax from baseline
with DDD-LV pacing was more sensitive at predicting
remodeling than echocardiographic parameters (Table 4).
Seventeen (94%) of 18 patients that remodeled had a 10%
rise in LV-dP/dtmax, with only 1 patient that had a 10% rise
in LV-dP/dtmax not RR (sensitivity 0.94, p  0.001,
compared with best echo parameter left ventricular pre-
ejection time sensitivity 0.82, p  0.06). ROC (Table 5)
showed an 11.1% rise in LV-dP/dtmax from baseline had a
sensitivity of 0.94 and specificity of 0.86 (p  0.009) to
predict RR, supporting the use of a 10% cutoff value to
distinguish between responders and nonresponders. A QRS
duration cutoff of 146 ms was found to be a good predictor
of RR. With ROC analysis, the only echocardiographic
parameter of dyssynchrony that had comparable sensitivity
and specificity was IVMD with a cutoff of 29 ms (sensitivity
0.94, specificity 0.79, p  0.003).
Etiology and remodeling. Thirteen (61%) patients with
DCM exhibited RR, compared with 5 (45%) with ICM.
(Table 6). There was a nonsignificant trend toward patients
with DCM having a greater percentage reduction in ESV
(19  21% vs. 8  28%). There was a strong relationship for
HR and RR for both DCM and ICM patients (p  0.01
nd p  0.006, respectively) (Figs. 3B and 3C). A similar
elationship was found with QRS duration and RR for both
CM and ICM patients (p  0.01 and p  0.04, respec-
ively). For patients with DCM, there was a statistically
ignificant relationship between SDI and RR (p 0.004) and
lso between IVMD and RR (p  0.006). For patients with
CM, the only echocardiographic parameter with statistically
ignificant relationships was IVMD and RR (p  0.006).
ead position. In 18 (54%) patients, the largest rise in
V-dP/dtmax was in a posterolateral vein (1 patient had the LV
ead turned off, due to phrenic nerve stimulation). Of these, 11
64%) remodeled. In 11 (33%) patients, the largest rise in
nLead Position
DDD-LV Pacing
insic
P/dtmax
AAI Pacing
Mean dP/dtmax Mean dP/dtmax % Change
148† 801 194 924 203† 18 18
123† 828 174 978 222† 19 16
164 795 255 894 178† 18 23
45 831 978 18
19 516 599 15
80 948 982 4sition LV
Intr
ean d
722
730
725
7
5
7rence from atrial antibradycardia pacing (AAI) (p  0.05).
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Hemodynamic Response Predicts Remodeling to Resynchronization September 6, 2011:1128–36LV-dP/dtmax was in a lateral vein, and 5 (45%) remodeled.
In 2 patients, the largest rise in LV-dP/dtmax was in a
osterior vein, with 1 patient remodeling. In 1 patient, optimal
V-dP/dtmax was in the middle cardiac vein, and the patient
emodeled. In 1 patient, the best position was the anterolateral
ein, but the subject did not remodel (Table 3).
linical response. Twenty-nine (91%) patients improved
y at least 1 NYHA functional class, and 30 (94%) patients
ad a 10% reduction in quality-of-life score. There was a
tatistically significant relationship between percentage rise
n LV-dP/dtmax and improvement in NYHA functional
lass and 10% reduction in quality-of-life score (p  0.02
for both). No relationship between QRS duration or echo-
Figure 2 Best and Worst Sites for Each Individual Pacing Posit
Percentage of change in LV-dP/dtmax from AAI or RV baseline LV-dP/dtmax for each
Abbreviations as in Figure 1.
Figure 3 Percentage Change in LV-dP/dtmax From Baseline for
(A) All patients; (B) patients with dilated cardiomyopathy; and (C) patients with is
other abbreviations as in Figure 1.cardiographic measures of dyssynchrony and measures of
clinical improvement were found.
Discussion
With invasive acute hemodynamic measurements at the
time of CRT implant we have shown: 1) there is a strong
relationship between the magnitude of rise in LV-dP/dtmax
from baseline for DDD-LV pacing and RR; 2) a 10%
ncrease in LV-dP/dtmax with DDD-LV pacing is a highly
ensitive and specific predictor of remodeling, which was
nderpinned by the ROC giving a cutoff of 11.1%;
) percentage rise in LV-dP/dtmax for LV pacing is better at
dual patient at best (blue bars) and worst (red bars) LV lead position.
-LV Pacing Plotted Against the Presence or Absence of LV RR
c cardiomyopathy. ESV  end-systolic volume; RR  reverse remodeling;ion
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September 6, 2011:1128–36 Hemodynamic Response Predicts Remodeling to Resynchronizationpredicting remodeling than QRS duration 120 ms and at
least as good as the best echocardiographic parameters of
dyssynchrony (IVMD); and 4) LV-dP/dtmax varies signifi-
antly, depending on site of LV lead positioning, and might
e useful for guidance.
emodeling and etiology. There was a nonsignificant
rend toward increased remodeling in DCM versus ICM
atients (61% vs. 45%). Acute response seemed similarly
redictive of remodeling in both groups. Fewer ICM
Figure 4 Relationship for Echocardiographic Parameters Prese
(A) The left ventricular pre-ejection (LVPE) period; (B) interventricular mechanical dela
(D) systolic dyssynchrony index (SDI) measured with 3-dimensional echocardiography
Sensitivity and Specificity for 10% Rise in LV-dP/dtmax for LV Pacintandard Echocardiographic Measures of Dyssynchrony PredictingTable 4 Sensitiv ty and Sp cificity for 10% Rise i LV-dP/dtmaxStandard Echocardiographic Measures of Dyssynchron
Assessment Method Cutoff Met? Total
% rise LV-dP/dtmax 10%, n  322 Yes 22
No 10
LVPE 140 ms, n  31 Yes 21
No 10
IVMD 40 ms, n  31 Yes 15
No 16
TDI septal lateral 80 ms, n  32 Yes 8
No 24
SDI 10.3%, n  26 Yes 16
No 10ESV end-systolic volume; IVMD interventricular mechanical delay; LV-dP/dtmaxmaximum rate of lef
TDI  tissue Doppler imaging.atients remodeling might be explained by the presence of
yocardial scar, producing a more varied response to CRT.
evertheless, the rise in LV-dP/dtmax might reflect contrac-
ile reserve and therefore provides an indicator of how likely
patient is to respond (28), independent of etiology. There
as a good relationship between QRS duration and remod-
ling in both DCM and ICM. For echocardiographic
arameters of dyssynchrony only IVMD delay was predictive
f response in ICM patients, suggesting that LV-dP/dtmax
r Absence of Left Ventricular Reverse Remodeling
); (C) septal lateral (SL) delay measured with tissue Doppler imaging (TDI); and
ESV  end-systolic volume.
dReduction in ESVV Pa ing a d
dicting 15% Reduction in ESV
n % Sensitivity Specificity p Value
7 77 0.94 0.64 0.001
1 10
4 67 0.82 0.5 0.06
3 30
3 86 0.76 0.86 0.001
4 25
4 50 0.22 0.71 0.7
4 56
2 75 0.8 0.64 0.02
3 30nce o
y (IVMD
(Echo).g an15%for L
y Pre
1
1
1
1
1t ventricular pressure; LVPE left ventricular pre-ejection time; SDI systolic dyssynchrony index;
a
p
r
s
p
b
h
d
i
t
r
d
a
t
h
w
r
d
d
r
w
i
p
s
r
C
i
(
q
r
i
f
p
p
R
a
1134 Duckett et al. JACC Vol. 58, No. 11, 2011
Hemodynamic Response Predicts Remodeling to Resynchronization September 6, 2011:1128–36might be particularly useful in determining which ICM
patients are likely to respond when conventional methods
are less helpful.
LV pacing site. In most patients the greatest percentage
rise in LV-dP/dtmax was in the posterolateral or lateral vein
(88%). In 4 patients (12%), although the LV-dP/dtmax was
ssessed in the posterolateral and lateral vein, the optimum
osition based on LV-dP/dtmax was a posterior, middle, or
anterolateral vein. Of these 4 patients, 50% remodeled. One
of these 4 had ICM with extensive transmural inferior
lateral scar, and the lead was placed in the anterolateral vein.
They had a 10% increase in LV-dP/dtmax and did not
remodel. It is unlikely this patient would have remodeled,
due to position and extent of scar. Recent published data
have demonstrated that pacing the site of latest mechanical
activation produces a better long-term prognosis and re-
modeling at 6 months (29). A further study (8) using an
individually based approach showed marked individual vari-
ation between patients and LV-dP/dtmax at different LV
pacing sites and concluded that an individually based
approach might be superior to empirical lead placement in
a posterolateral or lateral vein. We used epicardial pacing via
the coronary sinus, which limits the potential targets (3
patients had only 1 suitable vein). However, we found that,
with a targeted approach with LV-dP/dtmax, empirical
implantation of the LV lead in a posterolateral or lateral
vein does not always produce the best AHR. Notably some
LV lead positions were no better than AAI or RV pacing
(Figs. 1 and 2), emphasizing the importance of optimizing
LV lead placement.
Role of LV-dP/dtmax. Patients were recruited on the basis of
QRS duration120 ms. On this basis, only 18 (56%) patients
Sensitivity, Specificity, andAUC for 15% Redu tion i ESVTable 5 Sensitiv ty, Specificity, andAUC for 15% Reduction in ESV
Assessment Method AUC Cutoff Sensitivity Specificity
QRSD (ms), n  32 0.84 146.0 1.00 0.64
% rise LV dP/dtmax, n  32 0.89 11.1 0.94 0.86
LVPE (ms), n  31 0.75 160.0 0.65 0.79
IVMD (ms), n  31 0.91 29.0 0.94 0.79
TDI septal lateral (ms), n  32 0.5 90.0 0.88 0.29
SDI (%), n  26 0.8 11.9 0.73 0.82
Table uses receiver-operator characteristic curve analysis to investigate whether changing the
cutoff values used in Table 4 could give a better prediction of improvement in ESV.
AUC  area under the receiver-operator characteristic curve; QRSD  QRS duration; other
bbreviations as in Table 4.
Differences in Hemodynamic and Chronic Response Between DCMTable 6 Differences in Hemodynamic and Chronic Response Be
% Decrease in ESV >15% Decrease in E
All, n  32 16 24 18 (56%)
DCM, n  21 19 21 13 (61%)
ICM, n  11 8 28 5 (45%)Values are mean  SD or n (%). *Significant difference between AAI pacing (p  0.05).
DCM  dilated cardiomyopathy; ICM  ischemic cardiomyopathy; other abbreviations as in Table 3emodeled. For LV-dP/dtmax, 17 (94%) of the 18 patients that
remodeled had a10% rise in LV-dP/dtmax and only 1 patient
with a10% rise in LV-dP/dtmax did not remodel. The ROC
howed that a QRS cutoff of 146 ms was a far more sensitive
redictor of RR than 120 ms. Of 10 patients with a QRS
etween 120 and 149 ms, only 1 remodeled; this patient did
ave a 10% rise in LV-dP/dtmax. Although the numbers are
small, it is possible that LV-dP/dtmax could be beneficial in
determining responders in this group, because it would seem
that if the QRS is 150 ms and there is a 10% rise in
P/dtmax it is very unlikely remodeling will occur.
The IVMD was nearly equivalent in its predictive value
for remodeling as dP/dtmax. When groups were separated
nto DCM and ICM only IVMD was found to be predic-
ive of remodeling for both etiologies. We found no
elationship for septal lateral delay and remodeling. Three-
imensional echo-derived SDI was predictive of RR overall
nd in DCM patients but did not give superior discrimina-
ion compared with QRS duration alone and was not
elpful in ICM patients. Furthermore, 7 (22%) datasets
ere not analyzable, due to poor image quality.
Assessment of dP/dtmax is highly invasive (requires arte-
ial access), whereas conventional 2-dimensional echocar-
iographic assessment of dyssynchrony is not. However,
p/dt measurement is a more practical method to assess
esponse during the procedure, whereas echocardiography
ould be more difficult. The real benefit of the 2 predictors
s complementary. Echocardiography should be used to
redict who would respond before procedure, whereas dp/dt
hould be used intra-procedure to identify best site for
esponse.
linical implications. Symptomatically, 29 (91%) patients
mproved by at least 1 NYHA functional class, and 30
94%) patients had a 10% reduction in quality of life
uestionnaire score. There was a statistically significant
elationship between percentage rise in LV-dP/dtmax and
mprovement in quality of life questionnaire and NYHA
unctional class. For QRS duration and echocardiographic
arameters, no relationship was found. Up to 28% of
atients experience clinical response without significant LV
R (30). It could be inferred that using LV-dP/dtmax to
guide LV lead placement produces higher clinical responder
rates. However, there are few clinical nonresponders, and a
larger study is required to understand the relationship
between rise in LV-dP/dtmax and clinical response.
ICMn DCM and ICM
DDD-LV Pacing
AAI Pacing
Mean dP/dtmax Mean dP/dtmax % Change
798 197 910 188* 16 17
766 205 887 185* 19 18
857 173 953 193* 12 14andtwee
SV.
p
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d
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n
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l
s
D
L
i
d
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atients, it is difficult to fully understand the relationship
etween rise in LV-dP/dtmax and remodeling. We have
been able to show that LV-dP/dtmax is helpful at predicting
remodeling in all patients undergoing CRT, and although
we have shown that rise in LV-dP/dtmax seems to be helpful
in predicting response in DCM and ICM patients, greater
numbers are required to fully understand this relationship.
The high clinical responder rate means that this study is
underpowered to determine whether LV-dP/dtmax can pre-
ict which patients are likely to improve symptomatically.
We used DDD-LV pacing to determine the LV lead
osition rather than biventricular (BIV) pacing. It could be
rgued that determining the LV lead position with DDD-
IV pacing would be superior and more comparable to a
ormal resynchronization pacing strategy, but using
DD-LV pacing was the only option to ensure steady rate
or accurate hemodynamic measurements throughout the
tudy. Also, previous studies have demonstrated the nonin-
eriority of DDD-LV pacing compared with DDD-BIV
acing (9,11,31). Further studies are required with the LV
ead position optimized with BIV pacing to see whether
here are differences in final lead placement and whether this
hanges the long-term outcome, although a protocol opti-
izing every lead position with BIV pacing would run the
isk of having unfeasible procedure times.
The absence of a control group is a major limitation;
owever, our results highlight the potential of LV-dP/dtmax
to guide LV lead placement and improve response rates.
This study emphasizes the need for a randomized control
study of a guided versus conventional approach to CRT.
Conclusions
We have shown that a rise in LV-dP/dtmax from baseline to
guide LV lead position is helpful in predicting which
patients are likely to reverse remodel after CRT. Using a
10% rise in LV-dP/dtmax is superior to QRS duration and at
east as good as the best echocardiographic parameters at
electing which patients are likely to remodel both for
CM and ICM patients. This work supports the use of
V-dP/dtmax to aid in lead placement, and this might
mprove the responder rates in CRT with respect to
etermining which patients will remodel.
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